Literature DB >> 2582885

[Criteria for amputation, reconstruction and replantation of extremities in multiple trauma patients].

N Südkamp1, N Haas, P J Flory, H Tscherne, A Berger.   

Abstract

The paper defines indications for amputation, reconstruction and replantation of severely injured extremities of multiple traumatised patients using the trauma score PTS (Hannover Polytrauma Score) and the fracture grading for open and closed fractures.

Entities:  

Mesh：

Year:  1989        PMID： 2582885

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


  6 in total

Review 1.  [Operative strategies for hand injuries in multiple trauma. A systematic review of the literature].

Authors:  M Schädel-Höpfner; H Siebert
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

Review 2.  [Management strategies in the first operative phase after long-bone injury of the lower extremity in multiple-injured patients. A systematic literature review].

Authors:  D Rixen; S Sauerland; H-J Oestern; B Bouillon
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

3.  [Limb salvage and amputation after trauma : Decision criteria and management algorithm].

Authors:  C Krettek; A Lerner; P Giannoudis; C Willy; C W Müller
Journal:  Unfallchirurg       Date:  2016-05       Impact factor: 1.000

4.  What are predictors of mortality in patients with pelvic fractures?

Authors:  Joerg H Holstein; Ulf Culemann; Tim Pohlemann
Journal:  Clin Orthop Relat Res       Date:  2012-08       Impact factor: 4.176

5.  Complications of Open Tibial Fracture Management: Risk Factors and Treatment.

Authors:  Jyc Lua; V H Tan; H Sivasubramanian; Ebk Kwek
Journal:  Malays Orthop J       Date:  2017-03

6.  Pelvic Fractures in Children Results from the German Pelvic Trauma Registry: A Cohort Study.

Authors:  Jörn Zwingmann; Emin Aghayev; Norbert P Südkamp; Mirjam Neumann; Gerrit Bode; Fabian Stuby; Hagen Schmal
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.